Executive Summary

Chapter 1 - Introduction

Chapter 2 - Why do companies partner clinical stage compounds?
2.1. Introduction
2.2. The role of clinical stage partnering
2.2.1. In-licensing at clinical stage
2.2.2. Out-licensing at clinical stage
2.3. Difference between phase I, II and III stage deals
2.4. Reasons for entering into clinical stage partnering deals
2.4.1. Licensors reasons for entering clinical stage deals
2.4.2. Licensees reasons for entering clinical stage deals
2.5. The future of clinical stage partnering deals

Chapter 3 - Clinical stage deal strategies and structure
3.1. Introduction
3.2. At what stage do companies partner?
3.2.1. Partnering early in pharmaceutical/biotech
3.2.1.1. Discovery and preclinical stage partnering case studies
3.2.1.1.a. Case study 1
3.2.1.1.b. Case study 2
3.2.1.1.c. Case study 3
3.2.1.1.d. Case study 4
3.2.2. Partnering later in pharmaceutical/biotech
3.2.2.1. Clinical stage partnering case studies
3.2.2.1.a. Case study 5
3.2.2.1.b. Case study 6
3.2.2.1.c. Case study 7
3.2.2.1.d. Case study 8
3.3. Early and later stage partnering - a risk/cost comparison
3.4. What do companies spend on clinical stage partnering?
3.5. Pure versus multi-component partnering deals
3.6. Pure licensing agreement structure
3.6.1. Example pure licensing agreements
3.6.1.a. Case study 9
3.6.1.b. Case study 10
3.7. Multicomponent clinical stage partnering agreements
3.7.1. Example multicomponent clinical stage clauses
3.7.1.a. Case study 11

Chapter 4 - Clinical stage partnering payment strategies
4.1. Introduction
4.2. Clinical stage payment strategies
4.3. Payment options
4.3.1. Headline values
4.3.2. Upfront payments
4.3.2.1. Conditionality of upfront payments
4.3.3. Loans
4.3.4. Convertible loans
4.3.5. Equity
4.3.6. R&D funding
4.3.7. Licensing fees
4.3.8. Milestone payments
4.3.9. Royalty payments
4.3.9.1. Issues affecting royalty rates
4.3.9.2. Royalties on combination products
4.3.9.2.a. Case study 12
4.3.9.3. Guaranteed minimum/maximum annual payments
4.3.9.4. Royalty stacking
4.3.9.5. Royalties and supply/purchase contracts
4.3.10. Quids
4.3.11. Option payments

Chapter 5 - Trends in clinical stage deal making
5.1. Introduction
5.2. Clinical stage partnering over the years
5.2.1. Trends in phase I deals since 2015
5.2.1.1. Attributes of phase I deals
5.2.2. Trends in phase II deals since 2015
5.2.2.2. Attributes of phase II deals
5.2.3. Trends in phase III deals since 2015
5.2.3.1. Attributes of phase III deals
5.3. Clinical stage partnering by deal type
5.4. Clinical stage partnering by disease type
5.5. Partnering by clinical stage technology type
5.6. Clinical stage partnering by most active company since 2015

Chapter 6 - Payment terms for clinical stage partnering
6.1. Introduction
6.2. Guidelines for clinical stage payment terms
6.2.1. Upfront payments
6.2.2. Milestone payments
6.2.3. Royalty payments
6.3. Clinical stage payment terms - deal data analysis
6.3.1. Public data
6.3.2. Survey data
6.4. Payment terms analysis
6.4.1. Clinical stage partnering headline values
6.4.2. Clinical stage deal upfront payments
6.4.3. Clinical stage deal milestone payments
6.4.4. Clinical stage royalty rates

Chapter 7 - Leading clinical stage deals
7.1. Introduction
7.2. Top clinical stage deals by value

Chapter 8 - Top 25 most active clinical stage dealmakers
8.1. Introduction
8.2. Top 25 most active clinical stage dealmakers

Chapter 9 - Clinical stage partnering contracts directory
9.1. Introduction
9.2. Clinical stage deals with contracts since 2015

Chapter 10 - Clinical stage deal making by development stage
10.1. Introduction
10.2. Deals by clinical stage
Phase I
Phase II
Phase III
Regulatory

Appendices
Appendix 1 - Clinical stage dealmaking by companies A-Z
Appendix 2 - Clinical stage dealmaking by industry sector
Appendix 3 - Clinical stage dealmaking by stage of development
Appendix 4 - Clinical stage dealmaking by therapy area
Appendix 5 - Clinical stage dealmaking by technology type
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures
Figure 1: Definition of clinical phases in dealmaking
Figure 2: Components of the pure licensing deal structure
Figure 3: Payment options for clinical stage partnering deals
Figure 4: Issues affecting royalty rates
Figure 5: Clinical stage partnering by deal type since 2015
Figure 6: Clinical stage partnering by disease type since 2015
Figure 7: Clinical stage partnering by technology type since 2015
Figure 8: Top 25 most active clinical stage dealmakers, 2015 to 2022
Figure 9: Review of upfront payments for clinical stage deals
Figure 10: Review of milestone payments for clinical stage deals
Figure 11: Review of royalty payments for clinical stage deals
Figure 12: Clinical stage deals with a headline value
Figure 13: Clinical stage deals with an upfront value
Figure 14: Clinical stage deals with a milestone value
Figure 15: Clinical stage deals with a royalty rate value
Figure 16: Top clinical stage deals by value since 2015
Figure 17: Most active clinical stage dealmakers 2015 to 2022

Companies mentioned
2cureX, 2X Oncology, 3D BioMed, 3D Medicines, 3M Drug Delivery Systems, 3SBio, 4D Pharma, 4SC, 9 Meters Biopharma, AazeinTx, AB2 Bio, Abbisko Therapeutics, Abbott Laboratories, Abbott Vascular Devices, Abbvie, Abcam, Abdul Latif Jameel Health, ABEC, Abide Therapeutics, ABIVAX, ABL Bio, Ablynx, Abuse Deterrent Pharmaceuticals, ABX, Acacia Pharma, ACADIA Pharmaceuticals, Acasti Pharma, Acceliant, Accenture, Accord Healthcare, Accurexa, Acell, Acelrx Pharmaceuticals, Acelyrin, Acerta Pharma, Acer Therapeutics, Acerus, Acetylon Pharmaceuticals, Achieve Life Science, Achillion Pharmaceuticals, Acibadem University, AC Immune, Aclaris Therapeutics, Acrivon Therapeutics, Acrotech Biopharma, Actelion, Actigraph, Actinium Pharmaceuticals, ActualEyes, Acturum Life, Acuity Pharmaceuticals, Aculys Pharma, Acura Pharmaceuticals, Adagene, Adagio Therapeutics, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, ADC Therapeutics, Addario Lung Cancer Medical Institute, Addex Therapeutics, Adhera Therapeutics, Adial Pharmaceuticals, Adium Pharma, Adlai Nortye, adMare BioInnovations, Adocia, Adult Brain Tumor Consortium, Aduro BioTech, Advaccine Biotechnology, Advanced Accelerator Applications, Advanced Biological Laboratories, Advanced BioScience Laboratories, Advanced Regenerative Manufacturing Institute, Advanced Technology International, Advanz Pharma, Advaxis, Advent International, Adverum Biotechnologies, Aeglea BioTherapeutics, Aelix Therapeutics, Aerie Pharmaceuticals, Aeromics, Aerpio Pharmaceuticals, AEterna Zentaris, Aethlon Medical, Aevi Genomic Medicine, AffaMed Therapeutics, Affibody, Affimed Therapeutics, AFFiRiS, AFT Pharmaceuticals, AGC Asahi Glass, AGC Biologics, Agendia, AgeneBio, Agenus Bio, Agilent Technologies, Agios Pharmaceuticals, Agricultural Materials Company, Aguettant, AIDS Clinical Trials Group, Aileron Therapeutics, Aimmune Therapeutics, AiPharma Global Holdings, AiVita Biomedical, Ajinomoto Bio-Pharma Services, AJU Pharma, AkaRx, Akashi Therapeutics, Akcea Therapeutics, Akebia Therapeutics, Akero Therapeutics, Akili Interactive Labs, AKL Research and Development, Akorn, Akron Biotechnology, Akston Biosciences, Alat Medika Indonesia, Albany Molecular Research, Alba Therapeutics, Albert Einstein College of Medicine, Albireo, Alcami, Alder Biopharmaceuticals, Aldevron, Alector, Alexion Pharmaceuticals, Alfasigma, Algernon Pharmaceuticals, AliveGen, ALK-Abello, Alkahest, Alkem Laboratories, Alkermes, Allarity Therapeutics, Allecra Therapeutics, Allegro Ophthalmics, Allergan, Alliance For Clinical Trials In Oncology, Alliance for Lupus Research, Allied Corp, Alligator Bioscience, Allogene Therapeutics, Alloksys Life Sciences, Almac Group, Almirall, Alnylam Pharmaceuticals, Alpha Cognition, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpine Immune Sciences, ALS Association, Alseres Pharmaceuticals, ALS Finding a Cure Foundation, Altasciences, Alteogen, Alternavida, Altimmune, Altor BioScience, Altos Group, Altum Pharmaceuticals, Alume Biosciences, Alvogen, Alvotech, ALX Oncology, Alzamend Neuro, AlzeCure Pharma, Alzheimer's Drug Discovery Foundation, Alzheon, AlzProtect, AM-Pharma, Amag Pharmaceuticals, Amal Therapeutics, Amarantus BioSciences, Amarex Clinical Research, Amarin, Ambrx, Ambu, Amend Surgical, American Gene Technologies, American National Multiple Sclerosis Society, American Renal Associates, American Sexual Health Association, Amerigen Pharmaceuticals, Amgen, Amicus Therapeutics, Amneal Pharmaceuticals, AMO Pharma, Amoy Diagnostics, AMPEL BioSolutions, AmpliPhi Biosciences, Amplity Health, Amplyx Pharmaceuticals, AMR, Amryt, Amygdala Neurosciences, Amylyx Pharmaceuticals, Amyndas Pharmaceuticals, ANANDA Scientific, Anatara Lifesciences, Anavex Life Sciences, Andor Pharmaceuticals, Anergis, Angelini Pharma, AnGes MG, Angiochem, Angion Biomedica, Angionetics, AngioSoma, AnHeart Therapeutics, ANI Pharmaceuticals, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, AnnaMed, Annar Health Technologies, Annovis Bio, Antares Pharma, Antengene, Anteris Bio, Anthem, Anthony Nolan, Antibe Therapeutics, AntibioTx, Antigen Express, Antios Therapeutics, Antisense Therapeutics, AOP Orphan Pharmaceuticals, AOTI, Apceth, Apeiron Biologics, Apellis Pharmaceuticals, Apexian Pharmaceuticals, Apexigen, Aphex BioCleanse Systems, APL, Aplagon, Apogee Biotechnology, Apogenix, ApolloBio, Apollomics, Apollo Sugar, Appili Therapeutics, Applied Biology, Aprecia Pharmaceuticals, Apricus Biosciences, Apsen Farmacutica, Aptahem, Aptose Biosciences, Aquinox Pharmaceuticals, Araclon Biotech, Aranda Pharma, Aratana Therapeutics, Aravive Biologics, Arbormentis, Arbutus, Arcadia Biosciences, Arch Biopartners, Archer Daniels Midland Company, Arch Oncology, Arcoral Pharma, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Ardelyx, Arecor, Arena Pharmaceuticals, argenx, Argos Therapeutics, Aridis Pharmaceuticals, ARISE MD Integrative Medicine & Surgery, Aristea Therapeutics, Armata Pharmaceuticals, Armetheon, Arno Therapeutics (inactive since 2017), ArQule, Array Biopharma, Arrevus, Arrien Pharmaceuticals, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, ARS Pharmaceuticals, Artes Biotechnology, ARTMS Product, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Ascentage Pharma, Ascletis, Ashion Analytics, Asieris MediTech, ASKA Pharmaceuticals, AskAt, Asklepion Pharmaceuticals, Asklepios Biopharmaceutical, Aslan Pharma, Aspen Holding, Aspire Health Science, Aspyrian Therapeutics, Assembly Biosciences, Assistance Publique-Hôpitaux de Paris, Association for Frontotemporal Degeneration, Assurex Health, Assuta Medical Centers, Astellas Pharma, Asterias Biotherapeutics, Astex Pharmaceuticals, AstraZeneca, Asymchem Laboratories, ATAI Life Sciences, Atara Biotherapeutics, Atea Pharmaceuticals, ATGen Global, Athena Pharmaceutiques, Athenex, Athersys, Athira Pharma, Atlab Pharma, Atlantic Healthcare, Atnahs Pharma, Atossa Therapeutics, Atrapos Therapeutics, aTyr Pharma, Aucta Pharmaceuticals, Audentes Therapeutics, Auditus, AUM Biosciences, AUM Biotech, Aurinia Pharmaceuticals, Aurobindo Pharma, Australian Medical Research Institute, Autifony Therapeutics, Autism Impact Fund, Autism Speaks, Autobahn Therapeutics, AutoGenomics, Autolus, Autotelic, Autotelic BIO, Avacta, Avaria Health & Beauty, AVEO Oncology, Aveta Biomics, Avid Bioservices, Avillion, Awakn Life Sciences, AXIM Biotechnologies, Axovant Gene Therapies, Axsome Therapeutics, Azitra, AzurRx BioPharma, Bachem, Baker Brothers Investments, Baliopharm, Banner Alzheimer's Institute, Barbara Ann Karmanos Cancer Institute, Baruch S Blumberg Institute, Basilea Pharmaceutica, Battelle, Bausch & Lomb, Bausch Health Companies, Bavarian Nordic, Baxalta, Baxter International, Bayer, Bayer Healthcare, Baylor College, Baylor College of Medicine, BDD Pharma, Beckman Coulter, BeiGene, Beijing Clear Biotech, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Beijing SL Pharma, Beijing Tide Pharmaceutical, Beleave, Bellicum Pharmaceuticals, Bendalis, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benuvia Therapeutics, Berg, BerGenBio, Berlin Chemie, Besins Healthcare, Be The Match BioTherapies, Betta Pharmaceuticals, BetterLife Pharma, Better Therapeutics, Beyondspring Pharmaceuticals, Bhang, Bharat Biotech, BHV Pharmaceuticals, Bial, Bicycle Therapeutics, Bill and Melinda Gates Foundation, Binex, Bio-Manguinhos/Fiocruz, Bio-Path, Bio-Techne, Bio-Thera Solutions, BioAge Labs, BioAtla, BioAxone Therapeutic, BioBlast Pharma, BioCancell Therapeutics, BioCardia, Biocon, BioCorRx, BioCryst Pharmaceuticals, bioCSL, BioDelivery Sciences, Biodesix, BioElpida, Bioeq IP, Biofabri, Bio Farma, Bioforum, Biogen, BioGenetics, Biohaven Pharmaceutical Holding, BioInvent, Biokin Pharmaceutical, BiolineRX, Biological E, BioMarin Pharmaceutical, BioMatrix Specialty Pharmacy, Biomedical Advanced Research and Development Authority, BioMed Valley Discoveries, Biomerica, Biomica, Biomm, BiomX, Bioncotech Therapeutics, BiondVax, Bionical, Bioniz Therapeutics, BioNova Pharmaceuticals, BioNTech, BioPharma Services, Biophore Pharmaceuticals, Bioprojet, BioSense Global, BioSight, Biosplice, BioSun Pharmed, Biotechnology Industry Research Assistance Council, Biothera Pharmaceuticals, BioVaxys, BioVectra, Bioventus, BioVie, BioXcel, Biscayne Neurotherapeutics, BL&H, Blackstone, BlackThorn Therapeutics, Blake Insomnia Therapeutics, Blanver, Blinktbi, Bloom Science, Bluebird Bio, Blue Earth Diagnostics, Bluegrass Vascular Technologies, Blue Note Therapeutics, Blueprint Medicines, Boehringer Ingelheim, Bold Therapeutics, Bolt Biotherapeutics, Bone Therapeutics, Bonify, Bonnie J. Addario Lung Cancer Foundation, Bora Pharmaceuticals, Boryung Pharmaceutical, BostonGene, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Botanisol, Bpifrance, BrainScope, BrainStorm Cell Therapeutics, Brammer Bio, Breath Therapeutics, Breckenbridge Pharmaceutical, Breckenridge Pharmaceuticals, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Brigham and Women's Hospital, Brii Biosciences, Brill Pharma, Bristol-Myers Squibb, Broad Institute, Brown University, BryoLogyx, BTG, Burke Therapeutics, Burning Rock, Butantan Institute, C3i, Cadila Pharmaceuticals, Caelum Biosciences, Caladrius Biosciences, Calidi Biotherapeutics, California Institute for Regenerative Medicine, California Institute of Technology, Calithera Biosciences, Calliditas Therapeutics, Camargo Pharmaceutical Services, Camurus, Can-Fite BioPharma, Canadian Brain Tumour Consortium, Canadian Cancer Trials Group, Canadian Neuromuscular Disease Registry, Canagen Pharmaceuticals, Canbex Therapeutics, CANbridge Pharmaceuticals, Cancer Focus Fund, Cancer Genetics, Cancer Prevention and Research Institute of Texas, Cancer Prevention Pharmaceuticals, Cancer Research Technology, Cancer Research UK, Cancer Science Institute of Singapore, Cancer Targeted Technology, CanCure, Candel Therapeutics, CannaCure, Cannidex Brands, CanniMed Therapeutics, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, Canymed, Capillary Biomedical, Capricor Therapeutics, Cara Care, Cara Therapeutics, CARB-X, Cardiff Oncology, Cardinal Health, CardioFocus, Cardiome Pharma, Care Access Research, CareFirst BlueCross BlueShield, Caris Life Sciences, Carisma Therapeutics, Carmel Pharma, Carmentix, Carrick Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Cassava Sciences, Catabasis Pharmaceuticals, Catalent, Catalyst Clinical Research, Catalyst Pharmaceutical Partners, Catalyst Pharmaceuticals, CB2 Insights, CB2 Therapeutics, CBT Pharmaceuticals, CCT Research, Ceapro, Cedar Clinical Research, Cedars-Sinai Medical Center, Celcuity, Celdara Medical, Celgene, Celiac Disease Foundation, Celimmune, CellAct, Celladon, Cellastra, Cell Cure Neurosciences, Celldex Therapeutics, Cellectar Biosciences, Cellect Biotechnology, Cellectis, Cellenkos, Cellex, CellProThera, Cell Therapy Catapult, Celltrion, Cellular Biomedicine, Cellvation, Celonic, Cel Sci, Celsion, Celtic Biotech, Celyad, Cend Therapeutics, Cenexi, Censa Pharmaceuticals, Center for Cancer Research, Centers for Disease Control and Prevention, Centogene, Centre for Probe Development and Commercialization, Centre International de Developpment Pharmaceutique, Centre Leon Berard, Centrexion, Centurion, Cerecor, Certara, Cerulean Pharma, Cerus, Cevec Pharmaceuticals, CG Oncology, ChadTough Foundation, Changchun High & New Technology Industries, Checkmate Pharmaceuticals, Checkpoint Therapeutics, ChemoCentryx, Chemomab Therapeutics, Chi-Med, Chiesi Farmaceutici, Chime Biologics, Chimerix, China Grand Pharma, China Grand Pharmaceutical, China Medical System, China Resources Sanjiu Medical and Pharmaceutical, Chinese University of Hong Kong, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, ChromaDex, Chugai Pharmaceutical, CicloMed, Cidara Therapeutics, Cilag AG, CiMaas, CIMAB SA, Cincinnati Children's Hospital Medical Center, CinCor Pharma, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circuit Clinical, CIRION BioPharma Research, Citius Pharmaceuticals, Citrine Medicine, Citron Pharma, City of Hope, City of Hope Comprehensive Cancer Center, Civica Rx, CJ Corp, Clarity Pharmaceuticals, Clearside Biomedical, Cleave Therapeutics, Clementia Pharmaceuticals, Clene Nanomedicine, Cleveland BioLabs, Cleveland Clinic, Cleveland Diabetes Care, Clinical Genomics, Clinical Trial and Consulting Services, Clinica Universidad Navarra, Clinigen, Clinlogix, CloudCath, Clover Biopharmaceuticals, Clovis Oncology, CMAB Biopharma, CMC Biologics, Cmed, CMG Pharmaceutical, CMS Medical, CND Life Sciences, CNS Pharmaceuticals, Coala Life, Coalition for Epidemic Preparedness Innovations, Cobra Biologics, Codexis, Coeptis Pharmaceuticals, Cofactor Genomics, Cognition Therapeutics, Cognito Therapeutics, Coherus Biosciences, Cold Genesys, Collegium Pharmaceuticals, Color Genomics, Columbia Care, Columbia University, Commonwealth of Pennsylvania, Complement Pharma, Compugen, Conatus Pharmaceuticals, Concentric Analgesics, Concert Pharmaceuticals, Confluence Pharmaceuticals, Consilient Health, Constance Therapeutics, ConSynance Therapeutics, Context Therapeutics, ContraFect, ContraVir Pharmaceuticals, ConverGene, Convergent Therapeutics, Cook Biotech, Cook Medical, COPD Foundation, CORAT Therapeutics, Corbus Pharmaceuticals, Corden Pharma, CoreRx Pharma, Corino Therapeutics, Corium International, Cornell University, Corpometria Institute, Correvio Pharma, Cortendo, CorVascular, Corvus Pharmaceuticals, Cosmo Pharmaceuticals, COUR Pharmaceutical, Covance, COVAXX, Creapharm, Crescendo Biologics, Crescita Therapeutics, Crestone Pharma, CRISPR Therapeutics, Critical Path Institute (C-Path), Crohn's and Colitis Foundation of America, Cromos Pharma, CromSource, Crossject, CR Pharma, CRT Pioneer Fund, Cryolife, CryoPort, CrystalGenomics, CSIR-Central Drug Research Institute, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTD Holdings, CTI BioPharma, Cue Biopharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cura Partners, Curebase, CURE Pharmaceutical, Cures Within Reach, Curetis, CureVac, Curium, Curon Biopharmaceutical, Currax Pharmaceuticals, Curtana Pharmaceuticals, Custopharm, Cutaneous Lymphoma Foundation, Cutia Therapeutics, CyanVac, Cyclacel Pharmaceuticals, Cycle Pharmaceuticals, Cyclerion Therapeutics, Cyclopharm, Cyclo Therapeutics, CymaBay Therapeutics, Cynapsus Therapeutics, Cyntec, Cynvenio, Cyon Therapeutics, Cyprium Therapeutics, Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Cytiva, CytoAgents, Cytodyn, Cytokinetics, Cytori Therapeutics, CytoSen Therapeutics, Cytovance Biologics, Cytovation, Cyxone, D&D Pharmatech, Daavlin, Daewoong Pharmaceutical, Daiichi Sankyo, Dako, DalCor Pharmaceuticals, Dalhousie University, Dalton Pharma Services, Dana-Farber Cancer Institute, DanCann Pharma, Dance Biopharm, DanDrit Biotech, Danish Cancer Society Research Center, DARA BioSciences, Dare Bioscience, Dassault Systems, DAS Therapeutics, DCPrime, Debiopharm, Deciphera Pharmaceuticals, Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, Delcath Systems, DelMar Pharmaceuticals, Delpharm, Deltamune, Denali Therapeutics, Denovo Biopharma, Department of Defense, Department of Health and Human Services, Department of Veterans Affairs, DermapenWorld, Dermapharm, Dermavant Sciences, Dermin, Dermira, Desitin, Destiny Pharma, DeuteRx, Develco Pharma, Diaccurate, Dialco Medical, DiaMedica, Diamond Pharma Services, Diamond Therapeutics, Diamyd Medical, Dicerna Pharmaceuticals, Diffusion Pharmaceuticals, Dilaforette, Diopsys, Diurnal, Diversigen, DKSH, DNAtrix, Dong-A Pharmaceutical, Dong-A ST, Dongbao, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dragon Master Foundation, DreaMed Diabetes, Dreamy, DRI Capital, DSG, DuChemBio, Duchenne UK, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke Cancer Institute, Duke Clinical Research Institute (DCRI), Duke University, Durect, Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON), Dutch Emotional Brain, DyDo Pharma, Dynacure, Dynasil, Dynavax Technologies, Dyne Therapeutics, DynPort Vaccine Company, DySIS Medical, Dystonia Medical Research Foundation, Eagle Pharmaceuticals, Eczacibasi Pharmaceuticals, EDAP TMS, Eddingpharm, Edge Medical, Edge Pharma, Edith Wolfson Medical Center, Educational and Scientific, eFFECTOR Therapeutics, EffRx, EGeen, EicOsis, Eidos Therapeutics, Eiger BioPharmaceuticals, Eikonizo Therapeutics, EirGenix, EirGen Pharma, Eisai, Eisai Inc, Elanco, Elevai Labs, ElevateBio, Elevation Oncology, Eleven Biotherapeutics, Elicio Therapeutics, Eli Lilly, Elite Pharmaceuticals, Elixirgen, Ellipses Pharma, Elpiscience, ElsaLys Biotech, Eluminex Biosciences, Emerald Logic, Emerge Health, Emergent BioSolutions, Emmaus Life Sciences, Emmes, Emory University, Emtora Biosciences, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Pharmaceuticals, Endospan, Endo Ventures, ENDRA Life Sciences, Enlivex, Entasis Therapeutics, Enteris Biopharma, Enterome Bioscience, Enterprise Therapeutics, Entos Pharmaceuticals, Entourage Phytolab, Enumeral Biomedical, Enzene Biosciences, Enzychem Lifesciences, EOC Pharma, Eolas Therapeutics, EpicentRx, Epic Pharmaceuticals, Epic Sciences, EpiDestiny, EpiThany, Epizyme, EPS International, EQRx, Equinox Science, Er-Kim, Erasmus University Medical Center, Ergomed, Erytech, Especificos Stendhal, Esperance Pharmaceuticals, Esperion Therapeutics, Espero Biopharma, ESSA Pharma, Esteve, Ethypharm, Eton Pharmaceuticals, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Eurostars, Eureka Therapeutics, Eurocine Vaccines, Eurofarma, Eurofins Scientific, European Biomedical Research Institute of Salerno, European Commission, European Organization for Research and Treatment of Cancer, European Union, EUSA Pharma, Evaxion Biotech, Everest Medicines, Evergreen Theragnostics, Evergreen Therapeutics, EverInsight Therapeutics, EverlyWell, Eversana, EvoEndo, Evoke Pharma, Evolution Research Group, Evolve BioSystems, Evon Medics, Exact Therapeutics, Exagen Diagnostics, Exalenz Bioscience, ExCEEd Orphan, ExeGi Pharma, Exelixis, Exicure, Exothera, ExThera Medical, Eyenovia, EyePoint Pharmaceuticals, Eyevance, F-Star Therapeutics, F1 Oncology, F4 Pharma, Fabre Kramer Pharmaceuticals, Fagron, Fair Access Medicines, Fannin, Fareva Holding, FarmaMondo Group, Faron Pharmaceuticals, Federal Ministry of Education and Research (BMBF), Fedora Pharmaceuticals, Ferrer International, Ferring Pharmaceuticals, FightMND, First Horizon Pharmaceuticals, Five Prime Therapeutics, FKD Therapies, Flatiron Health, Florence, FluGen, FLX Bio, Foamix Pharmaceuticals, Food and Drug Administration (FDA), Forbius, ForDoz Pharma, Foresee Pharmaceuticals, Fortress Biotech, Forty Seven, Fosun Pharmaceutical, Foundation Fighting Blindness, Foundation Medicine, Fox Chase Cancer Center, Fred Hutchinson Cancer Research Center, Freeline Therapeutics, Freenome, Frequency Therapeutics, Fresenius Medical Care, Freya Pharma Solutions, Frontida BioPharm, Frontier Biotech, FSD Pharma, Fuhong Hanlin, Fujifilm, Fujifilm Diosynth Biotechnologies, Fujifilm Kyowa Kirin Biologics, Fujifilm Pharma, Fuji Pharma, Fuji Yakuhin, Fulcrum Therapeutics, FusionHealth, Fusion Pharmaceuticals, G-treeBNT, G1 Therapeutics, GABA Therapeutics, Galapagos, Galderma, Galectin Therapeutics, Galecto, Galena Biopharma, Galmed Pharmaceuticals, Gamaleya National Center, Gamida Cell, GAVI Alliance, GB Sciences, GC Pharma, Gebro Pharma, Gecko Biomedical, Gedeon Richter, GE Healthcare, Gemelli Teaching Hospital, Gemini Therapeutics, Gemphire, Gen, Genelux, Genentech, GeneOne Life Science, GenePeeks, Generex Biotechnology, Generon, GenesisCare, Genetic Technologies, Geneva Foundation, Genexine, Genfit, GenFleet Therapeutics, Genkyotex, Genmab, Genocea Biosciences, Genome and Company, Genor Biopharma, Genosity, Genotests, Genpharm, Genprex, GenScience Pharmaceuticals, GenScript Biotech, GenScript ProBio, Gensight Biologics, GenSpera, Genticel, Genzyme, Geom Therapeutics, Georgetown University, GeoVax, German Federal Ministry of Education and Research, German Government, Ghassan Aboud Group, Gibraltar Brothers and Associates, GI Dynamics, Gilead Sciences, GISCAD Foundation, Gland Pharma, Glaukos, GlaxoSmithKline, GL Brands, Glenmark Pharmaceuticals, GliaCure, Glide, Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Coalition for Adaptive Research, Global Drug Development Centre (GDCC) China, Global Medical Solutions, Global Response Aid, Global Stem Cell Technology, Globavir Biosciences, GlycoMimetics, GOG Foundation, Goodwin Biotechnology, Gossamer Bio, Government of Bahrain, Government of Canada, Government of France, Government of India, Government of Israel, Government of Japan, Government of Netherlands, Government of Singapore, Government of South Korea, Government of Switzerland, Gradalis, Granata Bio, Grand River Aseptic Manufacturing, Graviton Bioscience, Green Valley Pharmaceutical, Greenwich LifeSciences, Grifols, Gritstone Bio, Groupe Francophone des Myélodysplasies, Grow Biotech, Grunenthal, Grupo Juste, GT Biopharma, GT Medical Technologies, Guangzhou Xiangxue Pharmaceutical, Guardant Health, Guided Therapeutics, Gurnet Point Capital, GW Pharmaceuticals, GYD, Hadasit Bioholdings, Hadasit Medical Research Services and Development, Hadassah Medical Center, HaemaLogiX, Hainan Sihuan Pharmaceutical, Hainan Visum Pharmaceutical, Haisco Pharmaceutical, HalioDx, Halix, Halozyme Therapeutics, Hamilton Health Sciences, HanAll Pharmaceuticals, Hancock Jaffe Laboratories, Handok Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hannover Medical School, Hansa Biopharma, HanX Biopharmaceuticals, Harbour Biomed, Harmony Biosciences, Harpoon Therapeutics, Harrow Health, Harvard Medical School, Harvard University, Harvest One, Havn Life Sciences, Healios K.K., Healis Therapeutics, Healthcare Royalty Partners, HealthCore, Health Decisions, Health House International, Healx, Heat Biologics, HEC Pharm, Hefei Life Science, Heidelberg Pharma, Helix BioPharma, Helmholtz Zentrum Munchen, Helsinn Healthcare, Helsinn Therapeutics, HemispheRx Biopharma, Hemogenyx, Hemostemix, Henan Province People's Hospital, Henlius Biotech, Hepion Pharmaceuticals, Heritage Cannabis, Heritage Pharmaceuticals, HiberCell, Highlight Therapeutics, Hikma Pharmaceuticals, Hill Dermaceuticals, HistoIndex, Hitachi Chemical, HLS Therapeutics, HMNC Brain Health, Hoba Therapeutics, Hoffmann La Roche, Honda R&D Americas, Hookipa Pharma, Hoosier Cancer Research Network, Horizon 2020, Horizon Pharma plc, Hospira, Hoth Therapeutics, Houston Pharmaceuticals, HPGC Medical, Huapont Pharma, Humabs BioMed, Humacyte, Human Biosystems, Humanetics, Humanigen, Hummingbird Bioscience, Huons, Hutchison MediPharma, Hutchmed, Huyabio International, Hvidovre Hospital, Hyloris Pharmaceuticals, Hyundai Pharmaceutical, I-mab, IACTA Pharmaceuticals, IBSA Group, Icahn School of Medicine at Mount Sinai, iCardiac Technologies, IceCure Medical, Ichnos Sciences, ICM, Icon, IDEAYA Biosciences, Idera Pharmaceuticals, Idorsia, IDT, IDT Biologika, Ignyta, Iksuda Therapeutics, ILTOO Pharma, Image Analysis, ImageIQ, ImaginAb, ImClone Systems, Imeka, Immatics Biotechnologies, Immedica, Immix Biopharma, Immodulon Therapeutics, Immune Design, Immune Pharmaceuticals, Immune Regulation, Immunic, Immunicom, Immunicon, ImmunID Technologies, Immunitor, ImmunityBio, ImmunoBrain Checkpoint, ImmunoCellular Therapeutics, Immunocore, ImmunoGen, Immunomedics, Immunomic, ImmunoPrecise Antibodies, Immunovaccine, Immunovia, ImmuPharma, Immutep, IMPACT Therapeutics, Impax Laboratories, Impel NeuroPharma, Imperial College London, Impopharma, Impression Healthcare, Imugene, IMV, IncellDx, Inceptua, INC Research, Incyte, InDex Pharmaceuticals, Indivior, Infectious Disease Research Institute (IDRI), Infinity BiologiX, Infinity Pharmaceuticals, Inflection Biosciences, Inform Genomics, Inivata, Inmagene Biopharmaceuticals, INmune Bio, Innate Pharma, Innovare, Innovate Biopharmaceuticals, Innovate UK, Innovation Pharmaceuticals, Innovative Cellular Therapeutics, Innovent Biologics, Innovet, Innovus Pharmaceuticals, Inotrem, Inovio, Inovio Pharmaceuticals, Inserm, Insmed Inc, Inspirion Delivery Sciences, Inspirna, Institut Bergonie, Institute of Cancer Research, Institute of Human Virology, Institut Gustave Roussy, Institut Pasteur, Intas Pharmaceuticals, Intec Pharma, IntelGenx, Intellipharmaceutics, Intensity Therapeutics, InterCure, Interleukin Genetics, International Vaccine Institute (IVI), InteRx Biomedical, Intrommune Therapeutics, iNtRON Biotechnology, Intuitive Surgical, Invectys, Inventia Healthcare, InventisBio, inVentiv Health, INVO Bioscience, InxMed, IO Biotech, Ion Channel Innovations, Ionis Pharmaceuticals, Io Therapeutics, Iovance Biotherapeutics, IP Biotech, iPharma, Ippox Foundation, Ipsen, IPS Specials, IQVIA, IriSys, IRLAB, Iroko Pharmaceuticals, Ironwood Pharmaceuticals, IRX Therapeutics, ISA Pharmaceuticals, Isarna Therapeutics, ISA Scientific, Ischemix, Islet Sciences, Isofol Medical, ISOThrive, Israeli Ministry of Industry and Commerce, Israeli National Authority for Technological Innovation, Israel Investment Center, Italian Association for the Study of Pancreas, Italian Government, iTeos Therapeutics, Iterion Therapeutics, Iterum Therapeutics, ITM Isotopen Technologien, Itrom Pharmaceutical Group, Iveric Bio, Ivy Brain Tumor Center, iX Biopharma, IXICO, Izana Bioscience, Jackson Laboratory, Jaguar Health, Jain Foundation, JAMP Pharma Group, JanOne, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janssen Sciences, Japan Government, Japan Tobacco, Jasper Therapeutics, Jazz Pharmaceuticals, JCR Pharmaceuticals, JDP Therapeutics, Jeffrey Modell Foundation, Jenner Institute, Jerome Stevens Pharmaceuticals, Jesse's Journey, Jiangsu Alphamab, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Hengrui Pharmaceuticals, Jiangsu NHWA Pharmaceutical, Jiangsu Wuzhong Pharmaceutical, Jinzhou Ahon Pharma, JMT-Bio, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, John Wayne Cancer Institute, Journey Medical, JS InnoPharm, JT Pharmaceuticals, Jubilant DraxImage, Jumpcan Pharmaceutical, Juno Therapeutics, Junshi Biosciences, Jupiter Orphan Therapeutics, Juyou Biotechnology, JW Pharmaceutical, JW Therapeutics, Kabuki Syndrome Foundation, Kadimastem, Kadmon Pharmaceuticals, KAHR Medical, Kaken Pharmaceutical, Kalbe Genexine Biologics, Kaleido Biosciences, KaloBios Pharmaceuticals, KalVista Pharmaceuticals, Kamada, Kanazawa University, Kaneka, Karolinska Institute, Karuna Therapeutics, Karyopharm Therapeutics, Kazia Therapeutics, KBI BioPharma, Keck School of Medicine of USC, Kelun-Biotech Biopharmaceutical, Kemin Industries, KemPharm, Kennedy Krieger Institute, Kennedy Trust For Rheumatology Research, Kensington Pharma, Keros Therapeutics, Ketabon, Khandelwal Laboratories, Kiadis Pharma, Kineta, Kings College London, Kiniksa Pharmaceuticals, Kintor, Kirin Brewery, Kiromic Biopharma, Kissei Pharmaceutical, Kitanihon Pharmaceutical, Kite Pharma, Kitov Pharma, Knight Therapeutics, Kodiak Sciences, Kolltan Pharmaceuticals

Please contact our Customer Support Center to get the complete Table of Contents